-
Je něco špatně v tomto záznamu ?
Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe)
M. Gultekin, S. Ak, A. Ayhan, A. Strojna, A. Pletnev, A. Fagotti, AM. Perrone, BE. Erzeneoglu, BE. Temiz, B. Lemley, B. Soyak, C. Hughes, D. Cibula, D. Haidopoulos, D. Brennan, E. Cola, E. van der Steen-Banasik, E. Urkmez, H. Akilli, I....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2012
Free Medical Journals
od 2012
PubMed Central
od 2012
Europe PubMed Central
od 2012
ProQuest Central
od 2012-08-01
Open Access Digital Library
od 2012-01-01
Open Access Digital Library
od 2012-01-01
Health & Medicine (ProQuest)
od 2012-08-01
Wiley Free Content
od 2012
Wiley-Blackwell Open Access Titles
od 2012
ROAD: Directory of Open Access Scholarly Resources
od 2012
PubMed
33205595
DOI
10.1002/cam4.3605
Knihovny.cz E-zdroje
- MeSH
- COVID-19 epidemiologie prevence a kontrola virologie MeSH
- deprese psychologie MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- nádory ženských pohlavních orgánů psychologie terapie MeSH
- pandemie MeSH
- průzkumy a dotazníky * MeSH
- SARS-CoV-2 izolace a purifikace fyziologie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- strach psychologie MeSH
- úzkost psychologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa MeSH
BACKGROUND: The impact of the COVID-19 pandemic on European gynaecological cancer patients under active treatment or follow-up has not been documented. We sought to capture the patient perceptions of the COVID-19 implications and the worldwide imposed treatment modifications. METHODS: A patient survey was conducted in 16 European countries, using a new COVID-19-related questionnaire, developed by ENGAGe and the Hospital Anxiety & Depression Scale questionnaire (HADS). The survey was promoted by national patient advocacy groups and charitable organisations. FINDINGS: We collected 1388 forms; 592 online and 796 hard-copy (May, 2020). We excluded 137 due to missing data. Median patients' age was 55 years (range: 18-89), 54.7% had ovarian cancer and 15.5% were preoperative. Even though 73.2% of patients named cancer as a risk factor for COVID-19, only 17.5% were more afraid of COVID-19 than their cancer condition, with advanced age (>70 years) as the only significant risk factor for that. Overall, 71% were concerned about cancer progression if their treatment/follow-up was cancelled/postponed. Most patients (64%) had their care continued as planned, but 72.3% (n = 892) said that they received no information around overall COVID-19 infection rates of patients and staff, testing or measures taken in their treating hospital. Mean HADS Anxiety and Depression Scores were 8.8 (range: 5.3-12) and 8.1 (range: 3.8-13.4), respectively. Multivariate analysis identified high HADS-depression scores, having experienced modifications of care due to the pandemic and concern about not being able to visit their doctor as independent predictors of patients' anxiety. INTERPRETATION: Gynaecological cancer patients expressed significant anxiety about progression of their disease due to modifications of care related to the COVID-19 pandemic and wished to pursue their treatment as planned despite the associated risks. Healthcare professionals should take this into consideration when making decisions that impact patients care in times of crisis and to develop initiatives to improve patients' communication and education.
Clinica Universidad de Navarra Madrid Spain
Dance With Cancer Society Ankara Turkey
Department of Gynaecological Oncology Barts Health NHS Trust London UK
Department of Gynaecology National Institute of Oncology Budapest Hungary
Department of Gynecologic Oncology N N Alexandrov National Cancer Center of Belarus Minsk Belarus
Department of Gynecological Oncology Hollycross Cancer Center Kielce Poland
Department of Gynecology Imperial College London NHS Trust London London UK
Department of Obstetrics and Gynecology Alexandra Hospital University of Athens Athens Greece
Department of Oncology Lillebaelt Hospital University Hospital of Southern Denmark Vejle Denmark
Department of Surgery Institute Gustave Roussy Villejuif France
European Society of Gynaecological Oncoloy Executive Group Prague Czech Republic
Faculty of Medicine Department of Medical Oncology Hacettepe University Ankara Turkey
Faculty of Medicine Department of Psychiatry Hacettepe University Ankara Turkey
Gynecologic Oncology Unit La Paz University Hospital IdiPAZ Madrid Spain
K E F 1 Cancer Society Athens Greece
KIU Patient Organisation for Women with Gynaecological Cancer Copenhagen Denmark
Mallow Flower Foundation Budapest Hungary
Onko Unie Cancer Society Prague Czech Republic
Ovacome Ovarian Cancer Support Charity London UK
Radiotherapy Institute Arnhem The Netherlands
Sant Orsola Malpighi Hospital Bologna Italy
Stress Assesment and Research Center (STAR Hacettepe University Ankara Turkey
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21011644
- 003
- CZ-PrNML
- 005
- 20210507101840.0
- 007
- ta
- 008
- 210420s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/cam4.3605 $2 doi
- 035 __
- $a (PubMed)33205595
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Gultekin, Murat $u Faculty of Medicine, Department of Obstetrics and Gynecology, Division of Gynaecological Oncology, Hacettepe University, Ankara, Turkey $u European Society of Gynaecological Oncoloy (ESGO, European Network of Gynaecological Cancers Advocacy Groups (ENGAGe) Executive Group, Prague, Czech Republic
- 245 10
- $a Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe) / $c M. Gultekin, S. Ak, A. Ayhan, A. Strojna, A. Pletnev, A. Fagotti, AM. Perrone, BE. Erzeneoglu, BE. Temiz, B. Lemley, B. Soyak, C. Hughes, D. Cibula, D. Haidopoulos, D. Brennan, E. Cola, E. van der Steen-Banasik, E. Urkmez, H. Akilli, I. Zapardiel, I. Tóth, J. Sehouli, K. Zalewski, K. Bahremand, L. Chiva, MR. Mirza, M. Papageorgiou, N. Zoltan, P. Adámková, P. Morice, S. Garrido-Mallach, U. Akgor, V. Theodoulidis, Z. Arik, KD. Steffensen, C. Fotopoulou
- 520 9_
- $a BACKGROUND: The impact of the COVID-19 pandemic on European gynaecological cancer patients under active treatment or follow-up has not been documented. We sought to capture the patient perceptions of the COVID-19 implications and the worldwide imposed treatment modifications. METHODS: A patient survey was conducted in 16 European countries, using a new COVID-19-related questionnaire, developed by ENGAGe and the Hospital Anxiety & Depression Scale questionnaire (HADS). The survey was promoted by national patient advocacy groups and charitable organisations. FINDINGS: We collected 1388 forms; 592 online and 796 hard-copy (May, 2020). We excluded 137 due to missing data. Median patients' age was 55 years (range: 18-89), 54.7% had ovarian cancer and 15.5% were preoperative. Even though 73.2% of patients named cancer as a risk factor for COVID-19, only 17.5% were more afraid of COVID-19 than their cancer condition, with advanced age (>70 years) as the only significant risk factor for that. Overall, 71% were concerned about cancer progression if their treatment/follow-up was cancelled/postponed. Most patients (64%) had their care continued as planned, but 72.3% (n = 892) said that they received no information around overall COVID-19 infection rates of patients and staff, testing or measures taken in their treating hospital. Mean HADS Anxiety and Depression Scores were 8.8 (range: 5.3-12) and 8.1 (range: 3.8-13.4), respectively. Multivariate analysis identified high HADS-depression scores, having experienced modifications of care due to the pandemic and concern about not being able to visit their doctor as independent predictors of patients' anxiety. INTERPRETATION: Gynaecological cancer patients expressed significant anxiety about progression of their disease due to modifications of care related to the COVID-19 pandemic and wished to pursue their treatment as planned despite the associated risks. Healthcare professionals should take this into consideration when making decisions that impact patients care in times of crisis and to develop initiatives to improve patients' communication and education.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a úzkost $x psychologie $7 D001007
- 650 _2
- $a COVID-19 $x epidemiologie $x prevence a kontrola $x virologie $7 D000086382
- 650 _2
- $a deprese $x psychologie $7 D003863
- 650 _2
- $a strach $x psychologie $7 D005239
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a nádory ženských pohlavních orgánů $x psychologie $x terapie $7 D005833
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a pandemie $7 D058873
- 650 _2
- $a SARS-CoV-2 $x izolace a purifikace $x fyziologie $7 D000086402
- 650 12
- $a průzkumy a dotazníky $7 D011795
- 650 _2
- $a mladý dospělý $7 D055815
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Ak, Sertac $u Stress Assesment and Research Center (STAR, Hacettepe University, Ankara, Turkey $u Faculty of Medicine, Department of Psychiatry, Hacettepe University, Ankara, Turkey
- 700 1_
- $a Ayhan, Ali $u Faculty of Medicine, Department of Obstetrics and Gynecology, Division of Gynaecological Oncology, Baskent University, Ankara, Turkey
- 700 1_
- $a Strojna, Aleksandra $u Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, Szczecin, Poland
- 700 1_
- $a Pletnev, Andrei $u Department of Gynecologic Oncology, N.N. Alexandrov National Cancer Center of Belarus, Minsk, Belarus
- 700 1_
- $a Fagotti, Anna $u Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Heart, Rome, Italy
- 700 1_
- $a Perrone, Anna Myriam $u Sant Orsola-Malpighi Hospital, Bologna, Italy
- 700 1_
- $a Erzeneoglu, B Emre $u Faculty of Medicine, Department of Obstetrics and Gynecology, Division of Gynaecological Oncology, Hacettepe University, Ankara, Turkey
- 700 1_
- $a Temiz, B Esat $u Faculty of Medicine, Department of Obstetrics and Gynecology, Division of Gynaecological Oncology, Hacettepe University, Ankara, Turkey
- 700 1_
- $a Lemley, Birthe $u European Society of Gynaecological Oncoloy (ESGO, European Network of Gynaecological Cancers Advocacy Groups (ENGAGe) Executive Group, Prague, Czech Republic $u KIU - Patient Organisation for Women with Gynaecological Cancer, Copenhagen, Denmark
- 700 1_
- $a Soyak, Burcu $u Faculty of Medicine, Department of Obstetrics and Gynecology, Division of Gynaecological Oncology, Hacettepe University, Ankara, Turkey
- 700 1_
- $a Hughes, Cathy $u Ovacome - Ovarian Cancer Support Charity, London, UK $u Department of Gynecology, Imperial College London, NHS Trust London, London, UK
- 700 1_
- $a Cibula, David $u Department of Obstetrics and Gynecology, Gynecologic Oncology Center, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Haidopoulos, Dimitrios $u Department of Obstetrics and Gynecology, Alexandra Hospital, University of Athens, Athens, Greece
- 700 1_
- $a Brennan, Donal $u Department of Gynaecological Oncology, University College Dublin (UCD) School of Medicine, Catherine McAuley Research Centre, Mater University Hospital, Dublin, Ireland
- 700 1_
- $a Cola, Edoardo $u Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Heart, Rome, Italy
- 700 1_
- $a van der Steen-Banasik, Elzbieta $u Radiotherapy Institute, Arnhem, The Netherlands
- 700 1_
- $a Urkmez, Esra $u European Society of Gynaecological Oncoloy (ESGO, European Network of Gynaecological Cancers Advocacy Groups (ENGAGe) Executive Group, Prague, Czech Republic $u Dance With Cancer Society, Ankara, Turkey
- 700 1_
- $a Akilli, Huseyin $u Faculty of Medicine, Department of Obstetrics and Gynecology, Division of Gynaecological Oncology, Baskent University, Ankara, Turkey
- 700 1_
- $a Zapardiel, Ignacio $u Gynecologic Oncology Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain
- 700 1_
- $a Tóth, Icó $u European Society of Gynaecological Oncoloy (ESGO, European Network of Gynaecological Cancers Advocacy Groups (ENGAGe) Executive Group, Prague, Czech Republic $u Mallow Flower Foundation, Budapest, Hungary
- 700 1_
- $a Sehouli, Jalid $u Department of Gynecology with Center for Oncological Surgery, Charité-University Hospital, Berlin, Germany
- 700 1_
- $a Zalewski, Kamil $u European Society of Gynaecological Oncoloy (ESGO, European Network of Gynaecological Cancers Advocacy Groups (ENGAGe) Executive Group, Prague, Czech Republic $u Department of Gynecological Oncology, Hollycross Cancer Center, Kielce, Poland $u Department of Molecular and Translational Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland $u Department of Gynaecological Oncology, Barts Health NHS Trust, London, UK
- 700 1_
- $a Bahremand, Kiarash $u Department of Gynaecology, National Institute of Oncology, Budapest, Hungary
- 700 1_
- $a Chiva, Luis $u Clinica Universidad de Navarra, Madrid, Spain
- 700 1_
- $a Mirza, Mansoor Raza $u Department of Oncology, The Finsen Centre, Rigshospitalet - Copenhagen University Hospital, Copenhagen, Denmark
- 700 1_
- $a Papageorgiou, Maria $u European Society of Gynaecological Oncoloy (ESGO, European Network of Gynaecological Cancers Advocacy Groups (ENGAGe) Executive Group, Prague, Czech Republic $u K.E.F.I. Cancer Society, Athens, Greece
- 700 1_
- $a Zoltan, Novak $u Department of Gynaecology, National Institute of Oncology, Budapest, Hungary
- 700 1_
- $a Adámková, Petra $u European Society of Gynaecological Oncoloy (ESGO, European Network of Gynaecological Cancers Advocacy Groups (ENGAGe) Executive Group, Prague, Czech Republic $u Onko Unie Cancer Society, Prague, Czech Republic
- 700 1_
- $a Morice, Philippe $u Department of Surgery, Institute Gustave Roussy, Villejuif, France
- 700 1_
- $a Garrido-Mallach, Sonia $u Gynecologic Oncology Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain
- 700 1_
- $a Akgor, Utku $u Faculty of Medicine, Department of Obstetrics and Gynecology, Division of Gynaecological Oncology, Hacettepe University, Ankara, Turkey
- 700 1_
- $a Theodoulidis, Vasilis $u Department of Obstetrics and Gynecology, Alexandra Hospital, University of Athens, Athens, Greece
- 700 1_
- $a Arik, Zafer $u Faculty of Medicine, Department of Medical Oncology, Hacettepe University, Ankara, Turkey
- 700 1_
- $a Steffensen, Karina D $u European Society of Gynaecological Oncoloy (ESGO, European Network of Gynaecological Cancers Advocacy Groups (ENGAGe) Executive Group, Prague, Czech Republic $u Department of Oncology, Lillebaelt Hospital-University Hospital of Southern Denmark, Vejle, Denmark $u Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark $u Center for Shared Decision Making, Lillebaelt Hospital-University Hospital of Southern Denmark, Vejle, Denmark
- 700 1_
- $a Fotopoulou, Christina $u Department of Gynecology, Imperial College London, NHS Trust London, London, UK
- 773 0_
- $w MED00181704 $t Cancer medicine $x 2045-7634 $g Roč. 10, č. 1 (2021), s. 208-219
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33205595 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507101839 $b ABA008
- 999 __
- $a ok $b bmc $g 1650112 $s 1132023
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 10 $c 1 $d 208-219 $e 20201118 $i 2045-7634 $m Cancer medicine $n Cancer Med $x MED00181704
- LZP __
- $a Pubmed-20210420
